143148-29-2

Upstream product

• 143182-17-6 N-<1-(2-Phenyl-(N-benzylmalonyl)-aminoethyl)>-N-benzyloxycarbonyl-glycine t-butyl ester 

Downstream Products

• 150107-62-3 1-Phenyl-2,4-dioxo-3-(carbobenzyloxy)methyl-5-methyl-hexahydro-1,5-diazepine 
• 150107-64-5 1-Phenyl-2,4-dioxo-3-(carbobenzyloxy)methyl-5-(t-butyloxycarbonyl-aminomethyl)-hexahydro-1,5-diazepine 
• 150107-63-4 1-Phenyl-2,4-dioxo-3-(carbobenzyloxy)methyl-5-(carboxyamido)methyl-hexahydro-1,5-diazepine 

Relevant academic research and scientific papers

The use of γ-turn mimetics to define peptide secondary structure

A novel γ-turn mimetic 2 has been prepared based on retro amide peptide design. Incorporation of this mimetic into linear peptide fibrinogen receptor antagonist 7 (GPIIb/IIIa receptor) affords the opportunity to test models of antagonist pharmacophore.